EURO DIAGNOSTICA AB has a total of 29 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1988. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are NEXT BIOMED TECHNOLOGIES NBT O, ADVANCED LIFE SCIENCE INST INC and TOSCANA BIOMARKERS S R L.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | Australia | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | United States | 5 | |
#5 | Sweden | 3 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Measuring microorganism processes | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Dillner Joakim | 6 |
#2 | Trojnar Jerzy | 6 |
#3 | Tovey Michael | 4 |
#4 | Lallemand Christophe | 4 |
#5 | Ketelsen Anna | 4 |
#6 | Saellberg Matti | 3 |
#7 | Eriksson Haakan | 3 |
#8 | Sallberg Matti | 3 |
#9 | Varas Laura | 3 |
#10 | Sommarin Yngve | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019081643A1 | Secreted reporter-peptides for optimizing cell-based assays for analysis on immuno-assay platforms | |
WO2018185301A1 | System for the adaptation of cell-based assays for analysis on automated immuno-assay platforms | |
EP3191509A1 | Antibodies specific for complement component c4d and uses thereof | |
EP2383293A1 | Immunoassay for Chromogranin A, antibodies and kit | |
SE0701692L | Antigen Exposing Micell | |
AU7903100A | Peptide mixture and vaccine against a chronic viral infection | |
AU3809200A | Antinuclear antibody assay utilizing stress-treated cells or cell extracts | |
US5932412A | Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes | |
AU5520796A | Peptide-based vaccine against papillomavirus infection | |
SE9304291D0 | Peptide, diagnostic antigen and method of hepatitis C diagnosis |